The antagonism of para-aminobenzoic acid (PABA) to the chemotherapeutic action of sulfonamides in vitro and in vivo has long been established by various workers (McCarty, 1941; Selbie, 1940; Thomas and Dingle, 1942; Woods, 1940) . The studies of Woods and Fildes (Fildes, 1940; Woods, 1940; Woods and Fildes, 1940) provided, furthermore, a hypothetical picture of the metabolism of bacteria, based on the competitive antagonism of these two chemicals. The antagonism has also been extended to a sulfonamide-susceptible fungus by Dimond (1941) and malaria parasites by Seeler et al. (1943). The discovery of the chemotherapeutic action of sulfonamides on the lumphogranuloma venereum (LGV) virus (Felton et al., 1943; Findlay, 1940a,b; MacCallum and Findlay, 1938; McKee et al., 1942; Rodaniche, 1942) has led workers to investigate whether this antagonistic phenomenon of PABA and the sulfonamides could be applied to this sulfonamide-susceptible virus (Findlay, 1940; Rodaniche, 1942; Seeler et al., 1943). However, the work was controversial. Findlay (1940), feeding 10 mg sulfanilamide and 10 mg PABA suspended in gum acacia to mice, found that PABA antagonized the chemotherapeutic action of sulfanilamide for the LGV virus injected intracerebrally. His finding was based on the development of symptoms and the death rate in mice. In contrast to Findlay's finding, Seeler et al. (1943), using a diet containing 0.3 per cent, 0.03 per cent sulfanilamide and 0.3 per cent PABA, respectively, in one experiment, and 0.03 per cent sulfamethyldiazine and 0.3 per cent PABA in another, found that PABA showed no antagonistic action in mice that had previously been infected by the intracerebral route with their strain of the LVG virus. Their finding was based on the percentage of survivors 28 days after the infection. Rodaniche (1943) fed a diet containing 2 per cent sulfathiazole and 0.5 per cent PABA to intracerebrally infected mice and found no evidence of reversal at this ratio. However, when he used an equal amount of the two chemicals together, he found that the PABA exerted some antagonistic action.
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Since the psittacosis, lymphogranuloma venereum group of viruses have very close relationships, morphologically, developmentally, and tinctorially as well as antigenically (Rake et al., 1941) , and many of the members are susceptible to the chemotherapeutic action of the sulfa drugs, a reinvestigation of the discrepancies just mentioned seemed justified, particularly because of the possibility of discovering biochemical differences among members of the group.
The introduction of the intranasal method for the study of the psittacosis, lymphogranuloma venereum group of viruses by the examination of the extensiveness of the lung lesions (Nigg and Eaton, 1944; Shaffer et al., 1940) furnishes a more quantitative method of measuring the degree of infection than does intracerebral inoculation. We applied this method to the study of the antagonism of PABA on the chemotherapeutic action of sulfonamides for the LGV virus in mice and extended this investigation to developing chick embryos. Because the mouse pneumonitis virus has been found to be susceptible to sulfonamides (Eaton and Hanford, 1945; , similar experiments were done to see whether the same phenomenon occurred with this virus.
MATERIALS AND METHODS
Viruses. The J.H. strain of the virus of lymphogranuloma venereum and the Greb strain of the mouse pneumonitis viruses were used throughout the experiments. The mouse lungs were titrated after each passage for the production of stock virus and the 50 per cent maximum lesion score end point was determined (Horsfall, 1939;  Reed and Muench, 1938) by killing the mice 6 days after inoculation and grading the lesions. The dilution corresponding to the 50 per cent maximum lesion score end point was used for infecting the mice in our experiments.
For the egg experiments the yolk sac passages of the LGV and the mouse pneumonitis viruses stored in this laboratory were used. Their LDw had previously been determined by titration. A dose containing 10 to 100 LD60 was used in the experiments to be described.
Mice. Albino Swiss mice averaging 12 to 20 g in body weight were employed. They were bred in this department and rigid precautions have been taken against infection of any kind prior to use. In most of the experiments 12 mice were used for each dose of drug and 12 served as controls. The virus suspension was introduced intranasally in amounts of 0.05 ml, using light anaesthesia with ether. Drugs were administered intraperitoneally, first at 2 hours after inoculation with the viruis and then daily for 6 days. Variations of this schedule will be found in certain experiments. Control mice received 0.5 ml of normal saline by the intraperitoneal route at the same time as the animals under treatment. Surviving mice were autopsied on the sixth day after inoculation. Mice dying before the fifth day were autopsied, and the extent of the lung lesions was recorded.
Drugs. Sulfadiazine (S.D.) was used in the majority of the experiments. Sulfanilamide (S.A.) was used only in a few cases for comparison. Sulfadiazine tablets were ground into fine powder in a mortar and suspended in normal physio-74 [VOL. 58 logical saline. The volume was adjusted so that every 0.5 ml of the suspension would contain the required dose of the drug.
PABA was obtained from the Eastman Kodak Company. The sodium salt of this drug was employed instead of the acid itself.3 To prepare the sodium salt, the powder was dissolved in sufficient N/1 NaOH to bring the pH to 7.6, with 0.2 per cent phenol red as the indicator. The final volume was adjusted by adding enough physiological saline so that 0.5 ml ofthe solutionwould contain the required amount of the PABA.
RELATION OF LUNG WEIGHT TO CONSOLIDATION AND TO BODY WEIGHT
In the experiments to be described the degree of pulmonary consolidation was determined both by gross examination and by weighing the lungs. The results of gross examination were recorded as pulmonary lesion scores according to the method of Horsfall (1939) with certain modifications: the minute discrete foci frequently seen with viruses of the psittacosis-lymphogranuloma group were recorded as a score of 0.5 when less than one-eighth of the total amount of lung tissue was involved. Otherwise the pulmonary lesion scores were determined as before, and the total score for a given group of animals was divided by 5 times the number of animals in the group to give a percentage score representing the degree of pulmonary involvement.
The weight of the lungs was determined, as an average, by weighing together the lungs of all the mice in a group. It was, of course, evident that several factors other than the extent of pulmonary involvement would affect the weight of the lungs. The most obvious were the age and weight of the mice, and attempts were made to minimize these factors by selecting mice so that all groups were of approximately the same average body weight and age at the start of the experiment. The average weights of each group were, however, different at the conclusion of the experiment after a period of 6 days. The mice treated with sulfadiazine continued to grow and to gain weight more rapidly than the controls. The untreated mice gained weight more slowly or lost weight because of illness from the infection. Maximuim doses of PABA also tended to cause a loss of weight because of the toxicity of this substance at a dose of 40 mg per mouse, but smaller amounts were not toxic.
It was necessary, therefore, to assess the effects of dehydration, starvation, and cessation of growth on the weight of the lungs in normal mice and in those with pulmonary consolidation. Experiments with normal mice given toxic substances or subjected to dehydration and starvation revealed that no change of the lung weight occurred despite the loss of 20 to 35 per cent of the body weight as compared with control mice from the same group kept under normal conditions. It appeared from these results that in experiments ir which loss of body weight ' We found that when the same ratio of the acid and the sodium salt of PABA was used to a given amount of S.D. by weight, there was apparently no better antagonistic effect from the acid than from the sodium salt. Since the acid was more toxic and was more irritative to the peritoneum of the mouse when injected by this route, we therefore determined to use the sodium salt throughout our subsequent exPeriments.
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occurred the original weight of the mice could be taken as representative of the lung weight, and it was assumed that loss of body weight would in most instances be accompanied by cessation of growth of the lung tissue. In mice with consolidated lungs it is possible that dehydration might affect the weight of the lungs by reducing the amount of exudate, but data on this point are lacking at present.
When a gain of body weight occurred during the course of the experiment, this could be attributed largely to growth4 and the resulting increase in lung weight over the controls might give misleading results unless some corrections were This correction was then applied as follows: LWT-(BWT-BWC)K =LWT (corrected) in which BWT and BWc are body weights of treated and control mice, respectively, and LWT is the lung weight of treated mice. In all instances the maximum body weights were used regardless of whether they were obtained at the beginning or the end of the experiment for the reasons given in a previous paragraph. The value of K depends on the lesion scores of the treated mice as noted above. Examples of this correction will be given in the next section.
DETERMINATION OF THE AL EFFECTIVE DOSE OF SULFADIAZINE
The imal effective dose of various sulfonamides for the mouse pneumonitis virus has been determined (Eaton and Hanford, 1945) , but for the purposes of the present experiments a more exact measurement was necessary to adjust the dose to a level such that the degree of pulmonary consolidation of the treated mice would be reduced to about 50 per cent of that of the controls. The results with the mouse pneumonitis virus are summarized in table 1. In mice receiving doses of 0.5, 0.1, and 0.05 mg sulfadiazine per day, the lesion scores and lung weights were significantly lower than in the control mice. The effects of treatment are also reflected in the gain of body weight in the animals receiving sulfadiazine as contrasted with the controls.
In the fifth column of table 1 the lung weights of the treated mice have been corrected to correspond to a body weight equal to that of the controls as described in the previous section. For example, in the first line the correction is -(14.8 -13.5) X 0.006 = -0.0078 grams, a relatively insignificant amount because the weight changes in all groups of mice were in the same direction. In the fourth line of the table, however, a much larger correction is required, in this case -(14.6 -11.8) X 0.006 = -0.017 or about 17 per cent of the average lung weight of the treated mice. Consideration of the data in table 1 will reveal some irregularities in the amount of reduction of lung weight of the treated mice in 1949] relation to the dose of sulfadiazine, and the same is true of the lesion scores. It would appear therefore that small corrections in the lung weights would be overbalanced by other variables in the experiment. On the other hand, corrections of 10 per cent or greater may have some significance in the evaluation of the result, and their application seems justified.
The percentage of reduction in the lesion score and that in the lung weight in each case was calculated by the following formula: (-1 T/C) X 100, in which T represents the percentage lesion score or the lung weight of the treated animals, and C represents those for the control. From the results in table 1 it will be seen that 0.05 mg S.D. gave more than 50 per cent reduction in the lesion scores and more than 30 per cent reduction in the lung weights, which we consider quite significant. The minimal effective dose of sulfadiazine for the mouse pneumoni- The ratio between the antagonists in our experiments is much higher than those employed for the same phenomenon with bacteria and higher organisms. As a matter of fact, it may be partly due to the rapid excretion rate of the PABA in vivo, on one hand, and the higher sulfanilamide coefficient (Woods, 1942) of S.D., on the other. In order to verify the first point an experiment was. conducted in which the daily dose of 10 mg PABA was divided into 6 doses given 3 hours apart. The first 5 doses of 1 mg each were given intramuscularly, but the last dose of 5 mg was given together with the S.D. intraperitoneally. Under these conditions greater continuity of the blood level of the PABA in the body of the mouse could be expected. The sulfonamide used by the previous workers in experiments with the LGV virus was frequently sulfanilamide. Because of the fact that S.A. is less effective than S.D. for bacteria in terms of sulfanilamide coefficient, which is closely related to the amount of PABA needed to nullify the antibacterial effect of a given quantity of the sulfonamide (Woods, 1942) , it seemed worth while to carry out experiments on antagonism between the PABA and S.A. with these viruses in order to find out whether the same phenomenon applied here. Previous studies had indicated that the minimal effective dose of sulfanilamide for these viruses was 10 mg per mouse per day (Eaton and Hanford, 1945) 1949] those for the S.D. excepting that the mixture of the drugs was divided into two doses given 6 to 8 hours apart daily. This was to maintain a longer contact between the two antagonists in the body of the mouse and to minimize the rapid rate of excretion of the PABA in vivo. Complete antagonism of S.A. at a dose of 10 mg per day resulted when the PABA:S.A. ratio was 4: 1. There was no significant reversal when it was 1:1 in the case of the LGV virus, whereas almost complete reversal appeared at this same ratio in the case of the mouse pneumonitis virus. The differing molecular weights of S.D. and S.A. do not appreciably affect these differences in the ratios. A PABA:S.D. ratio of 400:1 in terms of weight is roughly 220:1 in terms of molecular weight, whereas the ratio of PABA:S.A. of 4:1 is 3.1:1 in terms of molecular weight.
EXPERIMENTS IN EGGS
Infection by the LGV and the mouse pneumonitis viruses in embryonic chicks through the yolk sac route was described some time ago Nigg and Eaton, 1944) . The therapeutic effect of sulfa drugs on these virus infections in eggs was also worked out (Eaton and Hanford, 1945; Jones et al., 1941) . However, the antagonism of PABA on the chemotherapeutic action of sulfonamide for these two viruses in eggs through the yolk sac infection has not been determined so far as we know. Further experiments were done by us to find the PABA: S.D. reversal ratio in infected eggs when these two viruses were used and to compare the results obtained with those for the mice, and with Morgan's (1948b) results with the 6BC strain of psittacosis.
Preliminary drug experiments showed that 2 mg of sulfadiazine was the minimal effective dose necessary to save 90 per cent or more of the infected eggs from the given dose of 10 to 100 LD60 of virus when compared with the controls, which received an equivalent amount of virus and physiological saline. Four mg of PABA (sodium salt) was the maximum dose tolerated by the embryos.
Test of antagonism. Three-tenths ml of the inoculum, which contained the desired dilution of either of the viruses diluted in nutrient broth, were introduced into the yolk sac of 7-day-old white Leghorn eggs, according to the usual method. Two hours later a mixture of the two drugs suspended in 0.3 ml saline, sterilized by being boiled in a water bath for 20 minutes, was introduced by the same route. The proportion of the drugs used is presented in tables 6 and 7. Only one injection of the mixture was given. Control eggs received an equivalent amount of sterile saline. A drug control with 2 mg of S.D. alone was conducted in some of the experiments for comparison. Eggs after inoculation were kept in the incubator at 36 C for 4 days. At the end of the fourth day they were candled. Dead eggs were regarded as nonspecific deaths and not counted in the nunmber of eggs tested. The eggs were candled daily thereafter, until the eleventh day. From the fifth to the eleventh day dead eggs were recorded. Survivors were sacrificed on the eleventh day.
To prove that the death was due to the virus, the following procedure was used: Examination for bacterial contamination by direct smear from the yolk sac was The mortality ratio, in which the numerator represents the number of dead embryos and the denominator the number tested, was used to indicate the results, and the percentage of reduction in the death rate between the treated and the control was compared by the formula (-1 T/C)100. The results of these experiments are presented in tables 6 and 7. From the data here it is clear that complete reversal of the chemotherapeutic action of the S.D. for both viruses began to appear only when 2 mg PABA and 2 mg S.D. were injected into the infected embryos. Partial but definite reversal occurred at ratios between 1:2 ad 1:10. With the LGV virus no reversal at all occurred when the PABA: S.D. ratio was reduced to the range between 1:40 and 1:400. With the mouse pneumonitis virus there was some evidence of partial reversal in one experiment at a ratio of 1:40. The PABA:S.D. ratio, from which complete antagonism of the effect of the sulfonamide was achieved, was much smaller than that for mice.
DISCUSSION
As indicated by the present data, there is clear evidence that PABA did antagonize the chemotherapeutic action of sulfonamides for infections with the viruses of lymphogranuloma venereum and mouse pneumonitis in mice and in chick embryos. This confirms Findlay's work (1940) for the LGV virus in mice. The discrepancies in the previous work were presumably attributable to the rapid excretion rate of the PABA in mice; if the PABA is not given in adequate amounts, a complete reversal on the effect of the sulfonamide will not be attained, especially when the results are judged by mortality alone.
According to D. D. Woods (1940) , the concentration of PABA required to overcome the chemotherapeutic action of sulfanilamide on the hemolytic streptococcus in vitro was 1/5,000 to 1/25,000, the concentration of sulfanilamide used. This is quite different from the same phenomenon with bacteria in mice. Selbie (1940) , using hemolytic streptococcus for his experiment in mice, found complete reversal of the action of the sulfanilamide only when 25 mg PABA and 25 mg S.A. were used. McCarty (1941) , testing the same phenomenon with pneumococcus type I in mice, found that complete reversal occurred only when the total dose of 6 mg PABA and 24 mg sulfapyridine were used together. The ratio was 1:4. Thomas and Dingle (1942) , performing the same experiment with meningococcus in mice and employing different methods of introduction of the drugs, found complete reversal of the effect of 0.005 mg S.D. when it was given together intraperitoneally with 1 mg PABA. The ratio was 200:1. Thus with bacteria the in vivo ratios for reversal were much larger than those for reversal of the sulfonamide activity in vitro.
It is quite possible that the rapid excretion of the PABA plays an important role in raising the ratio in mice. Martin and Rose (1945) found that the blood level of PABA following a single oral dose of 5 mg per 20-g mouse dropped from 12 mg per 100 ml within the first hour to almost nil in two hours, and that following a single subcutaneous dose of the same amount dropped from 20 mg per 100 ml within the first hour to zero in 3 hours. Although the determination of the amount of PABA recovered from the urine of the experimental mice is impractical, there is evidence to believe that a considerable amount, if not all, of the PABA must be excreted following the disappearance of the drug from the blood. Another factor is the relative rapidity of absorption of the PABA and S.D. from the peritoneum. The latter substance is relatively insoluble and therefore furnishes a depot in the peritoneum from which it is absorbed slowly, thus maintaining a rather persistent level of S.D. in the blood (Eaton and Hanford, 1945) . The PABA on the other hand may be absorbed more rapidly, reaching an initial high blood level and then declining so that in intervening periods only the S.D. is present. This difficulty is partly overcome by giving repeated doses of PABA spaced at short intervals of time. The distribution of the drugs in various tissues and the amount of acetylated derivative formed in vivo varies with different sulfonamides as shown by Strauss et al. (1941) , Peterson et al. (1941) , and Shannon (1943) . Similar differences in distribution and metabolic behavior between PABA and sulfadiazine may in part account for the high in vivo ratio.
Rapidity of excretion of the drugs has much less influence on the results with chick embryos. If we compare the data in tables 6 and 7 with the data of Morgan (1948b) , who found that complete reversal of the chemotherapeutic action of S.D. on his 6BC strain of psittacosis virus occurred even when 0.005 mg PABA and 2.5 mg S.D. (ratio 1:500) were used whereas there was no reversal when the ratio was reduced to 1:5,000, we discover a remarkable difference between his data and ours, although his computations were somewhat different from the data presented here. The differences between these findings might be due to the differences in the viruses employed. In fact our results, particularly in mice, indicate a slightly higher reversal ratio for the agent of lymphogranuloma venereum than for the mouse pneumonitis virus both with sulfadiazine and sulfanilamide. The reversal ratio in eggs for these agents is at least 10 times as great as that found by Morgan for the 6BC strain of psittacosis.
Several observations indicate that the nature of the organism may be involved in altering the PABA:S.D. ratio. Dimond (1941) has found that the inhibitive action of sulfanilamide on Trichophyton purpurum was completely nullified by PABA in a concentration as low as 1:500,000. This is very different from the concentration given by D. D. Woods (1940) for bacteria. On the other hand, Thomas and Dingle (1942) obtained a reversal of the effect of very small doses of S.D. on meningococcus when the PABA: S.D. ratio was 200:1, which is only one-fourth the ratio for the viruses we used in mice when the same drugs and the same route of administration of the drugs were employed. This finding is qualitatively in agreement with W. B. Wood's (1942) interpretation that the amount of PABA that nullified completely the antibacterial effect of a given quantity of the sulfonamide varied from organism to organism.
W. B. Woods also found that the ratio varied with a particular organism when different sulfonamides were used, and it has been found that the more effective the bacteriostatic power of the sulfonamide, the more PABA must be employed to give a complete reversal of its action. It has been found that sulfadiazine was 20 times more effective than sulfanilamide for bacteria if expressed in terms of the sulfanilamide coefficient. That sulfadiazine is at least a hundred times more effective than sulfanilamide was also found to be true in the treatment of mouse pneumonitis infection (Eaton and Hanford, 1945) . The difference between the PABA:S.D. and the PABA:S.A. ratios observed in our experiment in mice conforms with this finding. In the first case we found complete reversal when the ratio was 800:1, whereas in the latter the ratio was 1:4, which is one two-hundredth of the other.
As the viruses have not been grown in lifeless medium, however, reservations must be made in speaking of a quantitative measurement of this phenomenon, because the absorption, the excretion, the distribution, and the acetylation of the drugs in vivo must all be taken into consideration. Our results supplement Morgan's observations in indicating that these intermediate agents, although apparently obligate intracellular parasites, are closely related to bacteria so far as the metabolism of para-aminobenzoic acid is concerned. SUMMARY Para-aminobenzoic acid reverses the action of minimal therapeutic doses of sulfonamides in mice infected by the intranasal route with the viruses of mouse pneumonitis or lymphogranuloma venereum.
The PABA: sulfadiazine reversal ratios were between 800:1 and 200:1 in mice. PABA: sulfanilamide reversal ratios were between 4:1 and 1:1. Slight differences in the reversal ratios for the two viruses were noted.
In chick embryos inoculated by the yolk sac route with either of these two viruses, the PABA: S.D. reversal ratios were between 1: 2 and 1: 10.
The findings are similar to the results of analogous in vivo studieswith bacteria.
